News
Insulet has shown impressive revenue and profit growth, driven by its Omnipod System and expanding global presence. Read more ...
Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today ...
Fourth quarterIn constant exchange rates, net sales increased by 6 percent mainly driven by Europe and APAC. Reported sales increased by 3 percent amounting to SEK 5,156 M (5,023).Book-to-bill ratio o ...
Artedrone is trying to raise a €20 million Series B funding round to finalize its preclinical work and fund the ...
Artificial intelligence and robotics are revolutionizing drug discovery by automating laboratory processes and enabling rapid ...
News that 2,000 unsold and spanking new condos sit empty in Vancouver – where everyone says there’s a ‘housing crisis’ – made ...
The Global Intravenous Catheters Market is on a steady growth trajectory, driven by rising healthcare demands, an aging population, and continuous innovation in intravenous (IV) therapy technologies.
Nearly half of sequencing data labeled as endometriosis lacks true disease representation, highlighting the urgent need for more diverse and accurate tissue sampling to advance research in this ...
OXURION - Oxurion announces the signing of a binding agreement to acquire French biometrics specialist Axiodis CRO ...
Read the Market Summary Here:- https://reportocean.com/industry-verticals/sample-request?report_id=bw158 ...
13d
Zacks Investment Research on MSNNeurAxis Stock Gains Following Strong Q1 Earnings and FDA MilestonesShares of NeurAxis, Inc. NRXS have gained 13.3% since the company reported its earnings for the quarter ended March 31, 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results